Drug development for sickle-cell disease, largely neglected for decades, is becoming a crowded field: two papers published on Saturday in the New England Journal of Medicine give promising results from a study of experimental therapies, including Crisper gene editing for the disease. In addition, Beam Therapeutics Inc. The American Society …
Read More »
Dr .. Michelle Schultz Bayes, shifts overnight at St. Lucas Health System Hospitals near Idaho, treating several hundred critically ill Covid-19 patients filling hospital beds in her state during the most severe epidemic period so far. She, like many other health care workers, faces another challenge in light of the …
Read More »
Amazon.com has been one of the most innovative and disorganized companies of this century, with incredible success in areas beyond historically considered its core business (book sales). Thus every ad or speculation Amazon AMZN, -0.96% Whoever enters a particular industry sends the shares of that industry into the tailspin. Investors …
Read More »
Thomas H., president and chief executive of Equity Logic’s Stock Traders Daily. Key Jr. says that while there could be a big price of optimism in the markets, the rest of the year probably won’t see a decline in the big market. But it’s coming in 2021, he tells MarketWatch, …
Read More »
The stock index is gaining ground on Friday afternoon as investors look to reach a one-week high on Wall Street, largely optimistic about the prospect of a vaccine and treatment for Covid-1 for, while U.S. In the viral outbreak and ambush. Europe. Despite the lack of political momentum following the …
Read More »